Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz

Obere Zahlbacher Str. 63, Geb. 912, 55131 Mainz
  • 06131/17-9704 oder 9799 (Sekretariat)
  • 06131/17-9669
Publikationen
Ergebnisse pro Seite:  10


Bockamp, E; Abassi, Y; Robine, S et al.

A novel conditional mouse model for studying intestinal cancer

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 381. 2010 S. 84-84


Okuyama, M; Kayama, H; Atarashi, K et al.

A novel in vivo inducible dendritic cell ablation model in mice

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. Bd. 397. H. 3. 2010 S. 559-563


Cluny, NL; Vemuri, VK; Chambers, AP et al.

A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents

BRITISH JOURNAL OF PHARMACOLOGY. Bd. 161. H. 3. 2010 S. 629-642


Tomicic, MT; Reichmann, P; Rasenberger, B et al.

A novel role for c-Fos/AP-1 in the regulation of XPF endonuclease in UV-irradiated human fibroblasts

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 381. 2010 S. 72-72


Lytton, SD; Ponto, KA; Kanitz, M et al.

A Novel Thyroid Stimulating Immunoglobulin Bioassay Is a Functional Indicator of Activity and Severity of Graves' Orbitopathy

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 95. H. 5. 2010 S. 2123-2131


Daubner, T; Fink, A; Seitz, A et al.

A novel transmembrane domain mediating retention of a highly motile herpesvirus glycoprotein in the endoplasmic reticulum

JOURNAL OF GENERAL VIROLOGY. Bd. 91. 2010 S. 1524-1534



Cornely, OA; Vehreschild, JJ; Ruping, MJGT et al.

A phase II dose escalation study of caspofungin for invasive aspergillosis

MYCOSES. Bd. 53. H. 5. 2010 S. 376-377


Weidmann, E; Hess, G; Chow, KU et al.

A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas

LEUKEMIA & LYMPHOMA. Bd. 51. H. 3. 2010 S. 447-455